Results of the Phase III HERCULES trial suggest the first potential treatment option for a form of multiple sclerosis.

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...

Part of the partners' plan is to use Plex's AI to identify potential new uses for existing treatments that can be used to ...

Panakeia has announced the launch of the PANProfiler Colorectal (MSI/MMR), an AI-driven software solution that was designed ...

Array Bridge is testing promising drug candidates that can effectively bind and even degrade target proteins, but not via their active sites.

Researchers have engineered Lyme bacterial protein, CspZ, to produce a robust immune response in mice for vaccine development.

Mouse studies demonstrated that newly generated neurons connect with brain networks responsible for motor control.

Two new papers uncover IL-17 biology and add to growing evidence that cytokines can influence behavior during illness.

President Donald Trump’s exemption of pharmaceuticals from “reciprocal” tariffs limited the declines of biopharma stocks as ...

A study shows continued increase in antibiotic resistance is not inevitable and offers new insights to help monitor drug ...

Researchers hope MindGlide will unlock valuable information from millions of untapped brain images that were previously difficult or impossible to understand.

Biosimilar challenges include complex manufacturing processes and regulatory obstacles, offset by less regulated market ...